Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Rybelsus 3mg


Contraindicated
Reproductive toxicity in animals

Contraindicated
Rybelsus 3mg :
Type Medicine registered
Originator B
Agent Mersaco
Distributor Mersaco
Laboratory Novo Nordisk
Manufacturer Novo Nordisk AS
Origin Denmark
ATC A10BJ06

Your comment will appear shortly after approval

Rybelsus 3mg :

Revision Date : 26/07/2022


Effect Frequency
Abdominal distension Common
Abdominal pain Common
Amylase increased Common
Anaphylactic reactions Rare
Cholelithiasis (Calculus biliary) (Gallstones) Uncommon
Constipation Common
Decreased appetite Common
Diabetic retinopathy Complications Common
Diarrhoea (Diarrhea) Very Common
Dyspepsia Common
Eructation (belching) Uncommon
Fatigue Common
Flatulence Common
Gastritis Common
Gastrooesophageal reflux disease Common
Heart rate increased Uncommon
Hypersensitivity Uncommon
Lipase increased Common
Nausea Very Common
Pancreatitis acute Rare
Vomiting Common
Weight decreased (Weight loss) Uncommon

Different Units By MoH Code

Revision Date : 26/07/2022

Revision Date : 26/07/2022

Rybelsus 3mg  MoH 2065354 :
Form Tablet
Packaging Blisters (Al/Al)
Package Size Box of 30
Strength 3mg
Stratum N/A
NSSF ✘
Quarantine ✘
Reg. Number N/A
Submission date 26\04\2021
Registration Year 01/12/2022
Pending Year 17/11/2022
Pending Reason Incomplete file


Price Comparison

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info